![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LH Overby, S Nishio, A Weir, GT Carver, CG Plopper and RM Philpot
Laboratory of Cellular and Molecular Pharmacology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.
Induction of cytochrome P450 1A1 (P450 1A1) in a variety of tissues is a well established consequence of exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Although localization of the induced protein within the lung has been described, the precise intracellular distribution of the enzyme is not clear. Analysis of tissue sections, microsomal proteins, and mRNA from lungs of treated and untreated rabbits established that P450 1A1 had been induced by treatment with TCDD. Rabbit lungs from animals treated with TCDD were examined with immunocytochemistry and in situ hybridization, to identify the cell types that contain P450 1A1 and those that contain mRNA encoding P450 1A1. Endothelial cells of the entire vascular bed of rabbit lung reacted markedly with anti-P450 1A1. Likewise, cells lining both arteries and veins, as well as capillary endothelial cells, reacted strongly with the cDNA probe for mRNA encoding P450 1A1. Clara cells at all levels of airway labeled prominently for both P-450 1A1 and P450 1A1 mRNA. In addition, type 2 cells, alveolar macrophages, and to a lesser degree, ciliated cells reacted with the cDNA probe. P450 reductase, which is required for P450 activity, has previously been identified in Clara cells, type 2 cells, and alveolar macrophages, but not in endothelium of rabbit lung. We have now obtained similar results for the localization of mRNA encoding P-450 reductase. This finding brings into question the function of P450 1A1 in endothelium.
This article has been cited by other articles:
|
|
 |
|
  J. J. Schlezinger and J. J. Stegeman Dose and Inducer-Dependent Induction of Cytochrome P450 1A in Endothelia of the Eel, including in the Swimbladder Rete Mirabile, a Model Microvascular Structure Drug Metab. Dispos., June 1, 2000; 28(6): 701 - 708. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Ng, N. Kokot, T. Hiura, M. Faris, A. Saxon, and A. Nel Macrophage Activation by Polycyclic Aromatic Hydrocarbons: Evidence for the Involvement of Stress-Activated Protein Kinases, Activator Protein-1, and Antioxidant Response Elements J. Immunol., July 15, 1998; 161(2): 942 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lee, K. C. Watt, A.-M. Chang, C. G. Plopper, A. R. Buckpitt, and K. E. Pinkerton Site-Selective Differences in Cytochrome P450 Isoform Activities. Comparison of Expression in Rat and Rhesus Monkey Lung and Induction in Rats Drug Metab. Dispos., May 1, 1998; 26(5): 396 - 400. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Chen and D. W. Cheung Modulation of Endothelium-Dependent Hyperpolarization and Relaxation to Acetylcholine in Rat Mesenteric Artery by Cytochrome P450 Enzyme Activity Circ. Res., October 1, 1996; 79(4): 827 - 833. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
